RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 115 filers reported holding RELAY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,011,510 | -28.8% | 714,805 | +6.3% | 0.00% | 0.0% |
| Q2 2023 | $8,445,269 | -21.6% | 672,394 | +2.8% | 0.00% | -33.3% |
| Q1 2023 | $10,769,437 | +10.1% | 653,882 | -0.1% | 0.00% | 0.0% |
| Q4 2022 | $9,777,378 | -29.4% | 654,443 | +5.7% | 0.00% | -40.0% |
| Q3 2022 | $13,847,000 | +51.5% | 618,967 | +13.5% | 0.01% | +66.7% |
| Q2 2022 | $9,137,000 | -43.9% | 545,484 | +0.2% | 0.00% | -40.0% |
| Q1 2022 | $16,300,000 | +0.5% | 544,590 | +3.1% | 0.01% | 0.0% |
| Q4 2021 | $16,216,000 | +20.1% | 528,018 | +23.3% | 0.01% | +25.0% |
| Q3 2021 | $13,505,000 | +65.5% | 428,322 | +92.1% | 0.00% | +33.3% |
| Q2 2021 | $8,159,000 | +21.5% | 222,970 | +14.8% | 0.00% | +50.0% |
| Q1 2021 | $6,714,000 | +1.2% | 194,191 | +21.7% | 0.00% | -33.3% |
| Q4 2020 | $6,632,000 | +0.4% | 159,563 | +2.9% | 0.00% | 0.0% |
| Q3 2020 | $6,604,000 | – | 155,043 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |